391 related articles for article (PubMed ID: 36483555)
1. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
Front Immunol; 2022; 13():951135. PubMed ID: 36483555
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
3. The exploration of new biomarkers for oral cancer through the ceRNA network and immune microenvironment analysis.
Ma S; Guo J; Zhang X; Yang Y; Bao Y; Zhang S; Li T
Medicine (Baltimore); 2022 Dec; 101(49):e32249. PubMed ID: 36626444
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of circular RNA regulatory genes in competitive endogenous RNA network in gastric cancer.
Han T; Chen Z; Chen W; Yuan L; Liu B
Cancer Gene Ther; 2021 Nov; 28(10-11):1175-1187. PubMed ID: 33514881
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
[TBL] [Abstract][Full Text] [Related]
6. A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Li Y; Li R; Wang X; Yuan Y; Zhang Y
Biomed Res Int; 2021; 2021():6633289. PubMed ID: 33969120
[TBL] [Abstract][Full Text] [Related]
7. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel prognostic circRNA biomarkers in circRNA-miRNA-mRNA regulatory network in gastric cancer and immune infiltration analysis.
Yan J; Ye G; Jin Y; Miao M; Li Q; Zhou H
BMC Genomics; 2023 Jun; 24(1):323. PubMed ID: 37312060
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia.
Xue J; Chen H; Lu J; Zhang H; Geng J; He P; Lu X
Front Genet; 2023; 14():1203345. PubMed ID: 37388937
[No Abstract] [Full Text] [Related]
11. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Qi M; Yu B; Yu H; Li F
Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
[TBL] [Abstract][Full Text] [Related]
12. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma.
He Y; Yang D; Li Y; Xiang J; Wang L; Wang Y
Front Pharmacol; 2022; 13():949713. PubMed ID: 36532732
[No Abstract] [Full Text] [Related]
15. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer.
Song W; Ren J; Wang C; Ge Y; Fu T
Front Genet; 2020; 11():505. PubMed ID: 32582276
[TBL] [Abstract][Full Text] [Related]
16. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer.
Zhang L; Cao L; Liu J; Duan L; Zhou W; Li T; Guan L; Wu X; Zhang H
Aging (Albany NY); 2023 Jun; 15(11):5164-5189. PubMed ID: 37310469
[TBL] [Abstract][Full Text] [Related]
18. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
19. Identification of the KCNQ1OT1/ miR-378a-3p/ RBMS1 Axis as a Novel Prognostic Biomarker Associated With Immune Cell Infiltration in Gastric Cancer.
Yue T; Li J; Liang M; Yang J; Ou Z; Wang S; Ma W; Fan D
Front Genet; 2022; 13():928754. PubMed ID: 35910231
[No Abstract] [Full Text] [Related]
20. A novel pyroptosis gene expression-based risk score for survival in gastric cancer.
Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F
Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
